[Federal Register Volume 61, Number 192 (Wednesday, October 2, 1996)]
[Notices]
[Page 51434]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-25194]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE
National Institute of Standards and Technology


Notice of Prospective Grant of Coexclusive Patent License

SUMMARY: This is a notice in accordance with 35 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(i) that the National Institute of Standards and 
Technology (``NIST''), U.S. Department of Commerce, is contemplating 
the grant of a field of use coexclusive license in the United States to 
practice the invention embodied in U.S. Patent Number 5,389,523, 
titled, ``Liposome Immunoanalysis By Flow Injection Assay'' to Pasadena 
Scientific Industries, having a place of business in Hanover, Maryland 
and Saddleback Aerospace Corporation, having a place of business in 
Issaquah, Washington.

FOR FURTHER INFORMATION CONTACT: Bruce E. Mattson, National Institute 
of Standards and Technology, Industrial Partnerships Program, Building 
820, Room 213, Gaithersburg, MD 20899.

SUPPLEMENTARY INFORMATION: The prospective coexclusive license will be 
royalty-bearing and will comply with the terms and conditions of 35 
U.S.C. 209 and 37 CFR 404.7. The prospective coexclusive license may be 
granted unless, within sixty days from the date of this published 
Notice, NIST receives written evidence and argument which establish 
that the grant of the license would not be consistent with the 
requirements of 35 U.S.C. 209 and 37 CFR 404.7.
    U.S. Patent Number 5,389,523 is a method of immunoanalysis which 
combines immobilized immunochemistry with the technique of flow 
injection analysis, and employs microscopic spherical structures called 
liposomes, or lipid vesicles, as carriers of detectable reagents.
    NIST may enter into a Cooperative Research and Development 
Agreement (``CRADA'') with the licensees to perform further research on 
the invention for purposes of commercialization. NIST may grant the 
licensees an option to negotiate for coexclusive licenses to any 
jointly owned inventions which arise from the CRADA as well as an 
option to negotiate for coexclusive royalty-bearing licenses for NIST 
employee inventions which arise from the CRADA.
    The availability of the invention for licensing was published in 
the Federal Register, Vol. 57, No. 226 (November 23, 1992). A copy of 
the patent application may be obtained from NIST at the foregoing 
address.

    Dated: September 24, 1996.
Samuel Kramer,
Associate Director.
[FR Doc. 96-25194 Filed 10-1-96; 8:45 am]
BILLING CODE 3510-13-M